Background Mucosal Leishmaniasis (ML), a neglected tropical disease caused by
Leishmania parasites, impairs the quality of life of under-resourced populations in South …

The history of leishmaniasis dates back to the distant past; however, its etiologic agent was
unidentified until the mid-19th century. Here is an overview of some historical aspects of …

Introduction Laryngeal tuberculosis (LTB) is the most frequent granulomatous disease of the
larynx and represents less than 2% of extrapulmonary TB cases. There are no …

ABSTRACT About 85–90% of the market for new materials in biodegradable packaging is
served by various blends and composites containing starch in some portion. In an attempt to …

Background Empathy is paramount in the doctor-patient relationship being a comprehensive
and multidimensional concept. Self-ratings of empathy change across the years of medical …

BACKGROUND American tegumentary leishmaniasis (ATL) is a non-lethal parasitic disease
that presents with cutaneous (CL) and mucosal (ML) clinical forms. ATL treatment aims at …

Objective To compare the spatio-temporal distribution of cutaneous leishmaniasis (CL)
cases with mucosal leishmaniasis (ML) cases in the state of Rio de Janeiro (RJ) between …

ABSTRACT Introduction: Mucosal Leishmaniasis (ML) is a difficult to treat and severe form of
Leishmaniasis. In general, more than 40% of subjects with ML have therapeutic failure upon …

Mucocutaneous leishmaniasis and paracoccidioidomycosis are infectious diseases with
similar epidemiological and clinical aspects. Cases of both diseases may manifest similar …

Mucosal leishmaniasis (ML) is a rare clinical variant of tegumentary leishmaniasis in
Mediterranean Europe. Here we report on three autochthonous cases of head and neck ML …